The Technion and Carmel Medical Center, are rolling out a pilot that uses Irody’s technology for a close follow-up of Multiple Sclerosis out-patients. The patients are using mobile devices to track their condition and their use of medications. The medical staff have a dedicated poral through which they can review the information, in real-time, and iuntervene if neccesary. This project is funded by a grant from Teva, as part of Teva’s National Network of Excellence in Neuroscience (NNE) initiative.